Search: 15AM Faculty
Results 1 - 5 of 5

Doreen Valentine

Director, Global Medical
Bristol-Myers Squibb

Type of Company:
Pharmaceutical
Professional Degrees: BA/BS, CMPP, PhD
Other Degrees*: Certificate in Science and Technology Management, Professional Science Masters
CMPP Certified: (3/2016)

Bio: Doreen Valentine is Director for Translational Medicine and Biomarker Publications and Scientific Content at Bristol-Myers Squibb. In this role, Doreen leads a global team to develop strategic medical communications and execute on a tactical book-of-work that focuses on the application of precision medicine to the treatment of cancer. Before joining BMS in 2017, Doreen was a Senior Scientific Director at ClinicalThinking, a Nucleus Global Company, where she led a program supporting primary data publications and lifecycle communications for an immuno-oncology asset. Other medical communications and publications experience includes content strategy and creation for product launches and development of patient-centered materials in the agency setting, and full-length academic book publishing as an acquiring editor in the fields of public health, consumer health, psychology/mental health, and general medicine. Doreen served as the founding Associate Director of the Brain Health Institute at Rutgers University, where she also received a Professional Science Masters Certificate in Science and Technology Management. Doreen has a Bachelor of Science degree from Stony Brook University, with a double-major in biology and English (and is an alumna of the Alan Alda Center for Communicating Science at Stony Brook), and a PhD in neuroscience from Harvard Medical School. She is a Certified Medical Publication Professional since 2016 and resides in Princeton, New Jersey with a family of people and pets.

Joris van Rossum

Project Lead, Blockchain for Peer Review & Director
Digital Science
Professional Degrees: PhD

Bio: Dr. Joris van Rossum has been working for over 20 years in academic publishing, mostly in innovation and product development roles. He is currently leading the Blockchain for Peer Review initiative, a pilot project founded by leading publishers and organizations such as Digital Science, Springer Nature, Cambridge University Press and Taylor & Francis. For Digital Science, Joris researched the potential application of blockchain for science and research, which culminated in the 2017 report 'Blockchain or Research'. In 2015 he co-founded Peerwith, a marketplace for researcher services. Before that, Joris was Director of Publishing Innovation at Elsevier, where he focused on peer review innovation, article cascading, and author services. Earlier roles include Head of Scirus, a vertical search engine for scientific information, and Senior Product Manager for Scopus, where he was responsible for its content coverage.

Al Weigel

President/CEO
ISMPP

Type of Company:
Other
Professional Degrees: CMPP, MEd
CMPP Certified: (2/2009)

Bio: Al Weigel is President and COO for the International Society for Medical Publication Professionals (ISMPP). Al joined ISMPP in November of 2013 with primary responsibility for implementing the strategic goals and vision of the Society, in addition to ensuring the Society meets established milestones for ongoing development, growth and success. Prior to joining ISMPP, Al led cross-therapeutic medical publication and scientific communication teams at sanofi-aventis, Boehringer-Ingelheim and Celgene Corporation. Al earned his Masters of Education at the University of the Arizona and currently is a ISMPP Certified Medical Publication Professional (CMPP).

Christopher Winchester

Chief Executive Officer
Oxford PharmaGenesis

Type of Company:
Communications Agency
Professional Degrees: BA/BS, PhD

Bio: Chris Winchester is Chief Executive Officer of Oxford PharmaGenesis, an independent HealthScience communications consultancy with a strong heritage in publications. Now in its 21st year, Oxford PharmaGenesis employs over 250 communications professionals in Europe, North America and Asia Pacific. Chris is Chair of ISMPP, a founder of Open Pharma, led the development of the AMWA-EMWA-ISMPP Joint Position Statement on the role of the professional medical writer, and has been involved in collaborative research on the value of professional medical writing support. He has a doctorate in Biochemistry, has co-authored articles in the fields of cardiology, gastroenterology and respiratory medicine, and is an Associate Member of Green Templeton College at the University of Oxford.

Karen Woolley

Global Lead, Patient Partnerships
Envision Pharma Group

Type of Company:
Communications Agency
Professional Degrees: CMPP, PhD
CMPP Certified: (3/2010)

Bio: Professor Karen Woolley is the Global Lead for Patient Partnerships at Envision Pharma Group. She has 30 years of experience in the healthcare sector, gained in academia, hospital, industry, and agency environments in North America and the Asia Pacific region. Karen has served on ISMPP's Board of Trustees, established and chaired ISMPP's Asia Pacific Advisory Committee, and co-authored the Good Publication Practice 3 guidelines and the Joint Position Statement on Professional Medical Writers. She is a Certified Medical Publication Professional, an Honorary Fellow of AMWA, a Life Member of ARCS, and initiated the Global Alliance of Publication Professionals. In 2000, Karen co-founded the Asia Pacific medical communication agency, ProScribe, which she sold in 2014 to a leading global agency, Envision Pharma Group. Karen is also a Professor at two universities and has been a government-appointed director overseeing 6 hospitals, serving on the Patient Safety and Quality Committee, and managing a $2B budget. She has led international teams to conduct and publish research on publication ethics and on patient involvement in evidence generation and communication.